Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Conditions:   Hormone-resistant Prostate Cancer;   Recurrent Prostate CancerInterventions:   Drug: bicalutamide;   Drug: pazopanib hydrochloride;   Other: pharmacological study;   Other: laboratory biomarker analysisSponsor:   National Cancer Institute (NCI)Active, not recruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2007 Category: Research Source Type: clinical trials

Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Conditions:   Hormone-Resistant Prostate Cancer;   Recurrent Prostate CarcinomaInterventions:   Drug: Bicalutamide;   Drug: Pazopanib Hydrochloride;   Other: Pharmacological Study;   Other: Laboratory Biomarker AnalysisSponsor:   National Cancer Institute (NCI)Active, not recruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2007 Category: Research Source Type: clinical trials

Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Conditions:   Hormone-Resistant Prostate Cancer;   Recurrent Prostate CarcinomaInterventions:   Drug: Bicalutamide;   Drug: Pazopanib Hydrochloride;   Other: Pharmacological Study;   Other: Laboratory Biomarker AnalysisSponsor:   National Cancer Institute (NCI)Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2007 Category: Research Source Type: clinical trials

Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Conditions:   Hormone-Resistant Prostate Cancer;   Recurrent Prostate CarcinomaInterventions:   Drug: Bicalutamide;   Other: Laboratory Biomarker Analysis;   Drug: Pazopanib Hydrochloride;   Other: Pharmacological StudySponsor:   National Cancer Institute (NCI)Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2007 Category: Research Source Type: clinical trials

Abiraterone Acetate in Patients With Prostate Cancer Who Have Failed Hormone Therapy
Condition:   Prostate NeoplasmsInterventions:   Drug: Phase 1: abiraterone acetate;   Drug: Phase 2: abiraterone acetateSponsors:   Cougar Biotechnology, Inc.;   Cougar Biotechnology, Inc.Completed - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2007 Category: Research Source Type: clinical trials

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms
Conditions:   Vasomotor Symptoms;   Hot FlashesInterventions:   Drug: 0.5mg DRSP / 0.5mg E2 (BAY86-4891);   Drug: 0.25mg DRSP / 0.5mg E2 (BAY86-4891);   Drug: Estradiol (E2 0.3mg);   Drug: PlaceboSponsor:   BayerCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2007 Category: Research Source Type: clinical trials

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition:   Breast CancerInterventions:   Drug: Letrozole;   Other: PlaceboSponsors:   NSABP Foundation Inc;   National Cancer Institute (NCI);   NovartisActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2006 Category: Research Source Type: clinical trials

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
Condition:   Metastatic Breast CancerIntervention:   Sponsor:   AHS Cancer Control AlbertaTerminated - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2006 Category: Research Source Type: clinical trials

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Conditions:   Osteoporosis;   Prostate CancerInterventions:   Dietary Supplement: calcium carbonate;   Dietary Supplement: calcium citrate;   Dietary Supplement: calcium glucarate;   Dietary Supplement: cholecalciferol;   Drug: buserelin;   Drug: calcium gluconate;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Drug: zoledronic acid;   Radiation: brachytherapy;   Radiation: radiation therapySponsors: ...
Source: ClinicalTrials.gov - May 23, 2006 Category: Research Source Type: clinical trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions:   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: tamoxifen citrate;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Radiation: radiation therapy;   Other:&...
Source: ClinicalTrials.gov - March 31, 2006 Category: Research Source Type: clinical trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions:   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: tamoxifen citrate;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Radiation: radiation therapy;   Other:&...
Source: ClinicalTrials.gov - March 31, 2006 Category: Research Source Type: clinical trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions:   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: tamoxifen citrate;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Radiation: radiation therapy;   Other:&...
Source: ClinicalTrials.gov - March 31, 2006 Category: Research Source Type: clinical trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions:   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: tamoxifen citrate;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Radiation: radiation therapy;   Other:&...
Source: ClinicalTrials.gov - March 29, 2006 Category: Research Source Type: clinical trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions:   Estrogen Receptor Positive;   HER2/Neu Negative;   Progesterone Receptor Positive;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: Tamoxifen Citrate;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Radiation: Radiation Therapy;   Other: Laboratory Biomarker Analysis;   ...
Source: ClinicalTrials.gov - March 29, 2006 Category: Research Source Type: clinical trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions:   Estrogen Receptor Positive;   HER2/Neu Negative;   Progesterone Receptor Positive;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast CancerInterventions:   Drug: Tamoxifen Citrate;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Radiation: Radiation Therapy;   Other: Laboratory Biomarker Analysis;   ...
Source: ClinicalTrials.gov - March 29, 2006 Category: Research Source Type: clinical trials